Inspire Medical Systems, Inc. (NYSE:INSP) Stock Position Raised by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC lifted its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSPFree Report) by 37.3% during the fourth quarter, Holdings Channel reports. The firm owned 368 shares of the company’s stock after purchasing an additional 100 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Inspire Medical Systems were worth $68,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. True Wealth Design LLC acquired a new position in Inspire Medical Systems in the 3rd quarter worth approximately $30,000. Farther Finance Advisors LLC lifted its holdings in shares of Inspire Medical Systems by 1,158.3% in the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock valued at $32,000 after purchasing an additional 139 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Inspire Medical Systems by 559.3% in the third quarter. GAMMA Investing LLC now owns 178 shares of the company’s stock worth $38,000 after buying an additional 151 shares during the period. Quarry LP grew its holdings in shares of Inspire Medical Systems by 105.4% during the second quarter. Quarry LP now owns 343 shares of the company’s stock valued at $46,000 after buying an additional 176 shares in the last quarter. Finally, Signaturefd LLC raised its position in Inspire Medical Systems by 45.9% during the third quarter. Signaturefd LLC now owns 270 shares of the company’s stock valued at $57,000 after buying an additional 85 shares during the period. 94.91% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on INSP shares. Wells Fargo & Company raised their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 5th. Bank of America raised shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Stifel Nicolaus cut their target price on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a research report on Tuesday, January 21st. Royal Bank of Canada restated an “outperform” rating and set a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Finally, Piper Sandler reiterated an “overweight” rating and set a $260.00 price objective (up from $255.00) on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $231.45.

Check Out Our Latest Stock Analysis on Inspire Medical Systems

Inspire Medical Systems Price Performance

Inspire Medical Systems stock opened at $194.38 on Friday. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The company’s fifty day moving average price is $189.95 and its two-hundred day moving average price is $187.94. The company has a market capitalization of $5.83 billion, a price-to-earnings ratio of 181.67 and a beta of 1.32.

Inspire Medical Systems (NYSE:INSPGet Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The business had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same quarter in the prior year, the firm posted ($0.29) EPS. The firm’s revenue for the quarter was up 32.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Inspire Medical Systems, Inc. will post 1.35 earnings per share for the current year.

About Inspire Medical Systems

(Free Report)

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

Featured Stories

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSPFree Report).

Institutional Ownership by Quarter for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.